Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.

The New England journal of medicine·2024
Same author

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine.

Molecular therapy. Methods & clinical development·2022
Same author

Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.

Methods in molecular biology (Clifton, N.J.)·2018
Same author

Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.

The journal of gene medicine·2018
Same author

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Blood advances·2018
Same author

Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.

Oncotarget·2018

Related Experiment Video

Updated: Mar 28, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.3K

Insulated Foamy Viral Vectors.

Diana L Browning1, Casey P Collins2, Jonah D Hocum2

  • 11 School of Molecular Biosciences, Washington State University, Pullman.

Human Gene Therapy
|December 31, 2015
PubMed
Summary

Insulated foamy viral (FV) vectors show promise for gene therapy by reducing genotoxicity. The 650cHS4 insulator provided the best balance of safety and efficiency in hematopoietic stem cell applications.

More Related Videos

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI
06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI

Published on: May 24, 2022

3.1K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K

Related Experiment Videos

Last Updated: Mar 28, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
11:08

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles

Published on: April 8, 2012

36.3K
Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI
06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI

Published on: May 24, 2022

3.1K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K

Area of Science:

  • Gene Therapy
  • Molecular Biology
  • Hematopoietic Stem Cell Biology

Background:

  • Retroviral vector gene therapy faces limitations due to genotoxicity.
  • Foamy viral (FV) vectors offer a safer alternative, but internal promoters pose risks.
  • Gene activation near integration sites is a concern for vector safety.

Purpose of the Study:

  • To develop and compare insulated foamy viral (FV) vectors for enhanced safety in gene therapy.
  • To evaluate the efficacy of different insulator elements in FV vectors.
  • To assess the genotoxicity and integration profiles of insulated FV vectors.

Main Methods:

  • Development of FV vectors incorporating four distinct insulator elements: 650cHS4, synthetic CTCF-based, and 7xCTF/NF1.
  • Direct comparison of insulator activity, FV vector titer, and proviral integration fidelity.
  • Genotoxicity assessment and integration site analysis in CD34(+) hematopoietic stem cells.

Main Results:

  • Synthetic CTCF-based insulators demonstrated strong enhancer-blocking but reduced vector titers.
  • The 7xCTF/NF1 insulator showed weak insulating activity without affecting titers.
  • The 650cHS4-insulated FV vector emerged as the most promising, exhibiting reduced genotoxicity and fewer integration hotspots.
  • Both uninsulated and 650cHS4-insulated FV vectors were less genotoxic than gammaretroviral vectors.

Conclusions:

  • Insulated FV vectors, particularly the 650cHS4 variant, represent a promising advancement for safer hematopoietic stem cell gene therapy.
  • The 650cHS4 insulator effectively mitigates genotoxicity and improves integration site profiles in FV vectors.
  • Further development of insulated FV vectors could overcome previous safety concerns in clinical gene therapy applications.